Top of page
Lawyers

David R. Bauer

Lawyers

Filters

Davis Polk Advises Chemtura on Its Sale to LANXESS

Davis Polk is advising Chemtura Corporation in connection with its approximately $2.5 billion acquisition by LANXESS AG. The transaction, which is expected to close around mid-2017, is…

Spark Therapeutics Follow-On Offering

Davis Polk advised the representative of the underwriters in connection with the $181 million public offering of 4,025,000 shares of common stock of Spark Therapeutics, Inc. (“Spark”),…

SecureWorks Corp. Initial Public Offering

Davis Polk advised the joint book-running managers and representatives of the several underwriters on the $112 million initial public offering by SecureWorks Corp. of 8,000,000 shares of…

Mylan N.V. $1 Billion Notes Offering

Davis Polk advised the representatives of the initial purchasers on two Rule 144A/Regulation S offerings by Mylan N.V. of $500 million aggregate principal amount of its 3.000% senior notes…
Back to top